---
figid: PMC8945730__biomolecules-12-00371-g004
figtitle: 'Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection,
  Aging, and Neuroinflammation for the Modern Age'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
- Saccharomyces cerevisiae S288C
pmcid: PMC8945730
filename: biomolecules-12-00371-g004.jpg
figlink: /pmc/articles/PMC8945730/figure/biomolecules-12-00371-f004/
number: F4
caption: Proposed mechanism of EGCG autophagic response. Autophagy is a molecular
  recycling system explored extensively in cancer research. The promotion of molecular
  insults, i.e., ER stress, hypoxia, and chemotherapy, initiate the AMPK or MAPK/AKT/mTOR
  pathway, which recruits downstream effector protein kinases Unc-51 like autophagy
  activating kinase (ULK1/2,) and RP200 leading to the cascade of events leading to
  degradation of cellular debris. EGCG can act via AMPK or MTORC1 and act indirectly
  on autophagic-like proteins (ATG9) and ATG-9-15 to induce the autophagic series
  of events resulting in cellular debris breakdown and leading to the residue being
  reused for proper cellular growth and homeostasis.
papertitle: 'Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection,
  Aging, and Neuroinflammation for the Modern Age.'
reftext: Ashley Payne, et al. Biomolecules. 2022 Mar;12(3):371.
year: '2022'
doi: 10.3390/biom12030371
journal_title: Biomolecules
journal_nlm_ta: Biomolecules
publisher_name: MDPI
keywords: Alzheimerâ€™s disease (AD) | inflammation | oxidative stress | microglia |
  aging and epigallocatechin-3-gallate (EGCG)
automl_pathway: 0.9000524
figid_alias: PMC8945730__F4
figtype: Figure
redirect_from: /figures/PMC8945730__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8945730__biomolecules-12-00371-g004.html
  '@type': Dataset
  description: Proposed mechanism of EGCG autophagic response. Autophagy is a molecular
    recycling system explored extensively in cancer research. The promotion of molecular
    insults, i.e., ER stress, hypoxia, and chemotherapy, initiate the AMPK or MAPK/AKT/mTOR
    pathway, which recruits downstream effector protein kinases Unc-51 like autophagy
    activating kinase (ULK1/2,) and RP200 leading to the cascade of events leading
    to degradation of cellular debris. EGCG can act via AMPK or MTORC1 and act indirectly
    on autophagic-like proteins (ATG9) and ATG-9-15 to induce the autophagic series
    of events resulting in cellular debris breakdown and leading to the residue being
    reused for proper cellular growth and homeostasis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Crtc
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - MKP-4
  - p38b
  - rl
  - SNF4Agamma
  - AMPKalpha
  - Ack-like
  - Atg1
  - Atg13
  - Atg9
  - Atg12
  - Atg10
  - Atg5
  - Atg7
  - pe
  - Atg4a
  - Atg4b
  - Atg3
  - ctp
  - robl
  - Atg8a
  - MTOR
  - RPTOR
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - RP2
  - STK19B
  - NUDT19
  - ULK1
  - ATG13
  - ATG12
  - ATG10
  - ATG16L1
  - ATG5
  - ATG7
  - ATG4A
  - ATG4B
  - ATG4C
  - ATG4D
  - ATG3
  - DYNLL1
  - MAP1LC3A
  - ATG9
  - ATG4
---
